Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

Proper diagnosis is crucial to avoid overtreatment and complications in pregnant women with hyperthyroidism.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Routine genetic testing is crucial for early diagnosis and better management of Turner’s syndrome with 21-hydroxylase deficiency.

A woman's symptoms of increased body hair and testosterone were caused by a rare adrenal tumor, which was removed successfully.

Early diagnosis and personalized treatment are crucial for managing PCOS and preventing complications.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

A rare ovarian tumor caused early puberty in a 3-year-old girl.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

Blocking androgens at birth reduces sexual motivation in male rats.

Exposure to the hair loss drug finasteride during pregnancy can cause genital anomalies in male babies, but not in female babies. It's best to avoid this drug in women who could potentially become pregnant.

Prostaglandins may protect hair follicles during chemotherapy.

Prenatal antiandrogen treatment altered hormone levels in adult spotted hyenas, affecting males and females differently.

2% Minoxidil does not prevent hair loss during chemotherapy.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

SHBG may be a useful early indicator and treatment target for PCOS.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

Finasteride may reduce prostate cancer risk.

Kallmann syndrome can cause eye issues and other health problems, requiring various treatments.